No Data
CareRx Brief: Final Tranche of Unsecured Convertible Debentures Issued Have Been Converted Into Common Shares at a Price of C$3.00 per Common Share
CareRx Brief: Net Loss for Q3 $0.4 Million as Compared to a Net Loss of $1.4 Million for Q3 of 2023; Citing Continued Expansion of Adjusted EBITDA and EBITDA Margin
CareRx Corp (CHHHF) Q2 2024 Earnings Call Highlights: Operational Efficiency Boosts Adjusted ...
CareRx Brief: Consolidating Its Existing Burnaby and Vancouver Pharmacy Operations Into the New North Burnaby Location, Starting Early December 2024
CareRx Brief: Says Opening State-of-the-Art Pharmacy in British Columbia
CareRx Brief: Says Suzanne Brand Will Be Joining the Company in the Role of Chief Financial Officer Effective October 1, 2024
No Data